# A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

> **NCT07652047** · PHASE1 · RECRUITING · sponsor: **Corxel Pharmaceuticals** · enrollment: 90 (estimated)

## Conditions studied

- Obesity & Overweight

## Interventions

- **DRUG:** CX11
- **OTHER:** Placebo
- **DRUG:** CX11

## Key facts

- **NCT ID:** NCT07652047
- **Lead sponsor:** Corxel Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-11
- **Primary completion:** 2027-03
- **Final completion:** 2027-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652047, "A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*